(R)-2-Methoxy-2-(naphthalen-1-yl)propanoic acid, 95.0%, 100mg

(2-(2-Methoxyphenyl)pyrimidin-4-yl)methanol, 95%, 5g

2-Benzylhexahydrocyclopenta[c]pyrrol-4(2H)-one, 95.0%, 250mg

o-Tolylurea>98.0%(HPLC)25g

Ethyl 2-(naphthalen-1-yloxy)acetate, 98%, 5g

(3-Bromopyridin-4-yl)carbamic acid tert-butyl ester, 95.0%, 10g

Ethyl 3-(3-hydroxyphenyl)propanoate, 95.0%, 250mg

Manguera PFA, 1,6 mm, 3,2 mm, 5 m

2-(6-METHOXY-3-NITROPYRIDIN-2-YL)ACETONITRILE, 95.0%, 250mg

N-(tert-Butoxycarbonyl)-1,3-phenylenediamine>98.0%(GC)(T)5g

6'-(Pyridin-4-yl)-3,4':2',4''-terpyridine, 98%, 100mg

CY3-SE, 97%, 10mg

L-ValinaMide, N,N-diMethyl-L-valyl-N-[(1S,2R)-4-(1,1-diMethylethoxy)-2-Methoxy-1-[(1S)-1-Methylpropyl]-4-oxobutyl]-N-Methyl-, 98%, 250mg